Skip to main content
SpringerLink
Log in

Screening for Cancer of the Cervix

  • Chapter
Evaluation of Cancer Screening

Part of the book series: Focus on Cancer ((3292))

  • 62 Accesses

Abstract

Cervical cancer is the fifth most common cancer in the world, with over 400 000 new cases reported each year [81]. It is also one of the few cancers for which a screening test is available which is generally accepted as efficacious, despite the fact that it has never been evaluated by means of a randomised controlled trial. However, it is clear that although underlying trends in incidence make it difficult to estimate the effect of screening quantitatively, screening has so far failed to reduce the impact of the disease to the extent which might be thought feasible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aareleid T, Pukkali E, Thomson H, Hakama M (1993) Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs an unscreened population. Eur J Cancer 29A:745–749.

    Article  PubMed  CAS  Google Scholar 

  2. Ahluwalia MS, Doll R (1968) Mortality from cancer of the cervix in British Columbia and other parts of Canada. Br J Prev Soc Med 22:161–164.

    PubMed  CAS  Google Scholar 

  3. Aristazabel N, Cuello C, Correa P, Collazos T, Haenzel W (1984) The impact of vaginal cytology on cervical cancer risk in Cali, Colombia. Int J Cancer 34:5–9.

    Article  Google Scholar 

  4. Ayre JE (1947) Selective cytology smear for diagnosis of cancer. Am J Obstet Gynecol 53:609–617.

    PubMed  CAS  Google Scholar 

  5. Babes A (1928) Diagnostic du cancer du col uterin par les frattis. Presse Med 36:451–454.

    Google Scholar 

  6. Barton SE, Jenkins D, Cuzick J, Maddox PH, Edwards R, Singer A (1988) Effect of cigarette smoking on cervical epithelial immunity. Lancet ii:652–654.

    Article  Google Scholar 

  7. Beral V, Day NE (1992) Screening for cervical cancer: is there a place for incorporating tests for the human papillomavirus? In: Munoz N, Bosch FX, Shah KV, Meheus A (eds) The epidemiology of cervical cancer and human papillomavirus. IARC, Lyon, pp 263–269.

    Google Scholar 

  8. Boyes DA, Morrison B, Knox EG et al. (1982) A cohort study of cervical cancer screening in British Columbia. Clin Investigative Med 5:1–29.

    CAS  Google Scholar 

  9. Brinton LA, Fraumeni F Jr (1986) Epidemiology of uterine cervical cancer. J Chron Dis 39:1051.

    Article  PubMed  CAS  Google Scholar 

  10. Brinton LA, Reeves WC, Brenes MM et al. (1989) The male factor in the etiology of cervical cancer among sexually monogamous women. Int J Cancer 44:199–203.

    Article  PubMed  CAS  Google Scholar 

  11. Brinton LA, Reeves WC, Brenes MM et al. (1990) Oral contraceptive use and risk of invasive cervical cancer. Int J Cancer 19:4–11.

    CAS  Google Scholar 

  12. Brown J, Sculpher MJ (1993) Economics of screening programmes to prevent cervical cancer. Contemp Rev Gynaecol 5:221–229.

    Google Scholar 

  13. Campion MJ, Brown JR, McCance DJ et al. (1988) Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 95:175–181.

    Article  PubMed  CAS  Google Scholar 

  14. Celantano D, Klassen A, Weiseman C, Rosenhein N (1988) Cervical cancer screening practices among older women: results from the Maryland cervical cancer case-control study. J Clin Epidemiol 41:531–541.

    Article  Google Scholar 

  15. Chamberlain J, Pike C (1991) Fail-safe actions to ensure follow-up investigation of women with abnormal cytology; Guidelines. NHS Cervical Screening Programme. Muir Gray, Oxford.

    Google Scholar 

  16. Charny MC, Farrow SC, Roberts CJ (1987) The cost of saving a life through cervical cytology screening: implications for health policy. Health Policy 7:345–359.

    Article  PubMed  CAS  Google Scholar 

  17. Clarke EA, Anderson TW (1979) Does screening by “Pap” smears help prevent cervical cancer? A case-control study. Lancet ii:l–4.

    Google Scholar 

  18. Coppleson LW, Brown B (1975) Observation on a model of the biology of carcinoma of the cervix. A poor fit between observation and theory. Am J Obstet Gynecol 122:127–136.

    PubMed  CAS  Google Scholar 

  19. Cook GA, Draper GJ (1984) Trends in cervical cancer and carcinoma in-situ in Great Britain. Br J Cancer 50:367–375.

    Article  PubMed  CAS  Google Scholar 

  20. Cox B, Skegg DCG (1992) Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening. J Epidemiol Community Health 46:373–377.

    Article  PubMed  CAS  Google Scholar 

  21. Cramer D (1974) The role of cervical cytology in the declining morbidity and mortality from cervical cancer. Cancer 34:2018–2027.

    Article  PubMed  CAS  Google Scholar 

  22. Cuzick J, Boyle P (1988) Trends in cervix cancer mortality. Cancer Surveys 7:417–439.

    PubMed  CAS  Google Scholar 

  23. De Schryver A (1989) Does screening for cervical cancer affect incidence and mortality trends? The Belgian Experience. Eur J Clin Oncol 25:395–399.

    Article  Google Scholar 

  24. Ellman R (1991) Indications for colposcopy from a UK viewpoint. In: Miller AB, Day NE, Chamberlain J, Day NE, Hakama M, Prorok PC (eds) Cancer screening. UICC project of evaluation of screening for cancer. Cambridge University Press, Cambridge, pp 257–183.

    Google Scholar 

  25. Ellman R, Chamberlain J (1984) Improving the effectiveness of cervical cancer screening. J R Coll Gen Pract 34:537–542.

    PubMed  CAS  Google Scholar 

  26. Evaluation Committee (1989) Population screening for cervical cancer in the Netherlands. Int J Epidemiol 18:775–781.

    Article  Google Scholar 

  27. Evans DMD, Hudson EA, Brown CL et al. (1986) Terminology in gynaecological cytopathology: report of the Working Party of the British Society for Clinical Cytology. J Clin Pathol 39:933–944.

    Article  PubMed  CAS  Google Scholar 

  28. Flannelly G, Anderson D, Kitchener HC et al. (1994) Management of women with mild and moderate cervical dyskaryosis. Br Med J 308:1399–1403.

    Article  CAS  Google Scholar 

  29. Fletcher A (1990) Screening for cancer of the cervix in elderly women. Lancet 335:97–99.

    Article  PubMed  CAS  Google Scholar 

  30. Fletcher A, Metaxas N, Grubb C, Chamberlain J (1990) Four and a half year follow-up of women with dyskaryotic cervical smears. Br Med J 301:641–644.

    Article  CAS  Google Scholar 

  31. Frisch LE, Parmar H, Buckley LD, Chalem SA (1990) Improving the sensitivity of cervical cytologic screening. A comparison of duplicate smears and colposcopic examination of patients with cytologic inflammatory epithelial changes. Acta Cytologica 34:136–139.

    PubMed  CAS  Google Scholar 

  32. Giles JA, Hudson E, Crow J, Williams D, Walker P (1988) Colposcopic assessment of the accuracy of cervical cytology screening. Br Med J 296:1099–1102.

    Article  CAS  Google Scholar 

  33. Griffiths M (1992) Screening for cervical cancer in developing countries. Br Med J 304:984.

    Article  CAS  Google Scholar 

  34. Greenberg RS, Chow W, Liff JM (1989) Recent trends in the epidemiology of cervical neoplasia. Acta Cytol 33:463–469.

    PubMed  CAS  Google Scholar 

  35. Habbema JDF, Lubbe JTN, van Oortmarssen GJ, van der Maas PJ (1987) A simulation approach to cost-effectiveness and cost-benefit calculations for early detection of disease. Eur J Op Res 29:159–166.

    Article  Google Scholar 

  36. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 293:659–664.

    Article  Google Scholar 

  37. Johannesson G, Geirsson G, Day N (1978) The effect of mass screening in Iceland, 1965–1974, on the incidence of cervical carcinoma. Int J Cancer 21:418–425.

    Article  PubMed  CAS  Google Scholar 

  38. Jones MH, Jenkins D, Cuzick J et al. (1992) Mild cervical dyskariosis: safety of cyto-logical surveillance. Lancet 339:1440–1443.

    Article  PubMed  CAS  Google Scholar 

  39. Kirby AJ, Spiegelhalter DJ, Day NE et al. (1992) Conservative treatment of mild/ moderate cervical dyskariosis: long-term outcome. Lancet 339:828–831.

    Article  PubMed  CAS  Google Scholar 

  40. Kjellgren O (1986) Mass screening in Sweden for cancer of the uterine cervix: effect on incidence and mortality. An overview. Gyncecol abstract. Lancet 22:56–63.

    Google Scholar 

  41. Kjaer SK, de Villiers E-M, Haugaard BJ et al. (1988) Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer 41:518–524.

    Article  PubMed  CAS  Google Scholar 

  42. Knox EG (1973) A simulation system for screening procedures. In: McLachlan G (ed) The future and present initiatives. (Problems and progress in medical care IX.) Nuffield Provincial Hospitals Trust, Oxford, pp 19–30.

    Google Scholar 

  43. Kuroishi T, Hirose K, Tominaga S (1986) Evaluation of the efficacy of mass screening for uterine cancer in Japan. Japan J Cancer Res 77:399–405.

    CAS  Google Scholar 

  44. Lancet (1985) (editorial) Death by incompetence. Lancet ii:363–364.

    Google Scholar 

  45. La Vecchia C, Franceschi S, Decarli A et al. (1984) “Pap” smear and the risk of cervical neoplasia; quantitative estimates from a case-control study. Lancet ii:779–782.

    Article  Google Scholar 

  46. Louhivouri K (1991) Effect of a mass screening programme on the risk of cervical cancer. Cancer Detect Prev 15:471–474.

    Google Scholar 

  47. Luesley DM, Cullimore J, Redman CWE et al. (1990) Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears. Br Med J 300:1690–1693.

    Article  CAS  Google Scholar 

  48. Luthra UK, Rengachari R (1986) Organization of screening programmes in developing countries with reference to screening for cancer of the uterine cervix in India. In: Hakama M, Miller AB, Day NE (eds) Screening for cancer of the uterine cervix. IARC, Lyon, pp 273–285.

    Google Scholar 

  49. Lynge E, Madsen M, Engholm G (1989) Effect of organised screening on incidence and mortality of cervical cancer in Denmark. Cancer Res 49:2157–2160.

    PubMed  CAS  Google Scholar 

  50. MacGregor JE, Moss SM, Parkin DM, Day NE (1986) Cervical cancer screening in north-east Scotland. In: Hakama M, Miller AB, Day NE (eds) Screening for cancer of the uterine cervix. IARC, Lyon, pp 25–36.

    Google Scholar 

  51. Miller AB, Lindsay J, Hill GB (1976) Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 17:602–612.

    Article  PubMed  CAS  Google Scholar 

  52. Modan B (1993) Screening for cervical cancer — should the routine be challenged? Eur J Cancer 29A:2320–2325.

    Article  PubMed  CAS  Google Scholar 

  53. Moss SM (1991) Case-control studies of screening. Int J Epidemiol 20:1–6.

    Article  PubMed  CAS  Google Scholar 

  54. Murphy MFG, Campbell MJ, Goldblatt PO (1987) Twenty years’ screening of the uterine cervix in Great Britain, 1964-84: further evidence for its ineffectiveness. J Epidemiol Community Health 42:49–53.

    Article  Google Scholar 

  55. Murthy NS, Agarwal S, Prabhakar AK, Sharma S, Das DK (1993) Estimation of reduction in life-time risk of cervical cancer through one life-time screening. Neoplasma 40:255–258.

    PubMed  CAS  Google Scholar 

  56. Narod SA, Thompson DW, Jain M et al. (1991) Dysplasia and the natural history of cervical cancer: early results of the Toronto cohort study. Eur J Cancer 27:1141–1416.

    Article  Google Scholar 

  57. Noguchi M, Nakanishi M, Kato K (1982) Appraisal of a newly developed self-collection device for obtaining cervical specimens. Acta Cytologica 26:633–635.

    PubMed  CAS  Google Scholar 

  58. Office of Population Censuses and Surveys (1993) Cancer statistics: cause, 1987. Series MB1, no. 20. HMSO, London.

    Google Scholar 

  59. Office of Population Censuses and Surveys (1993) Mortality statistics: cause 1992. Series DH2, no. 19. HMSO, London.

    Google Scholar 

  60. Olesen F (1988) A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int J Epidemiol 17:501–508.

    Article  PubMed  CAS  Google Scholar 

  61. Papanicolaou GM, Traut HF (1941) The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet and Gynecol 42:193–206.

    Google Scholar 

  62. Parkin DM (1985) A computer simulation model for the practical planning of cervical cancer screening programmes. Br J Cancer 51:551–568.

    Article  PubMed  CAS  Google Scholar 

  63. Parkin DM, Pisani P, Ferlay J (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606.

    Article  PubMed  CAS  Google Scholar 

  64. Pedersen E, Haeg K, Kolstad P (1971) Mass screening for cancer of the uterine cervix in Ostfold County, Norway. An experiment. Acta Obstet Gynecol Scand Suppl 11.

    Google Scholar 

  65. Pisani P, Parkin DM, Ferlay J (1993) Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891–903.

    Article  PubMed  CAS  Google Scholar 

  66. Raymond L, Obradovic M, Riotton G (1984) A case-control study to estimate the detection of cancer of the cervix uteri by cytology. Rev Epidemiol Sante Publique 32:10–15.

    PubMed  CAS  Google Scholar 

  67. Robertson AJ, Anderson JM, Swanson Beck J et al. (1989) Observer variability in the histopathological reporting of cervical biopsies. J Clin Pathol 42:231–238.

    Article  PubMed  CAS  Google Scholar 

  68. Royal College of Obstetricians and Gynaecologists (1987) Report of the Intercollegiate Working Party on Cervical Cancer Screening. Royal College of Obstetricians and Gynecologists, London.

    Google Scholar 

  69. Sasieni P (1991) Trends in cervical cancer mortality. Lancet 338:818–819.

    Article  PubMed  CAS  Google Scholar 

  70. Schiffman MH, Bauer HM, Hoover RN et ai. (1993) Epidemiologie evidence showing that human papilloma virus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Instit 85:958–964.

    Article  CAS  Google Scholar 

  71. Sigurdsson K (1993) Effect of organised screening on the risk of cervical cancer. Evaluation of screening activity in Iceland. Int J Cancer 54:563–570.

    Article  PubMed  CAS  Google Scholar 

  72. Silcocks PBS, Moss SM (1988) Rapidly progressive cervical cancer: is it a real problem? Br J Obstet and Gynaecol 95:1111–1116.

    Article  CAS  Google Scholar 

  73. Singh V, Sehgal A, Luthra UK (1992) Screening for cervical cancer by direct inspection. Br Med J 304:534–535.

    Article  CAS  Google Scholar 

  74. Soe MM (1992) Screening for cervical cancer in developing countries. Br Med J 304:983–984.

    Article  CAS  Google Scholar 

  75. Stafl A (1981) Cervicography — a new approach to cervical cancer detection. Gynecol Oncol 12:5292–5301.

    Article  Google Scholar 

  76. Stjernsward J, Eddy D, Luthra U, Stanley K (1987) Plotting a new course for cervical cancer screening in developing countries. World Health Forum 8:42–45.

    Google Scholar 

  77. Tawa K, Forsythe A, Coye K, Saltz A, Peter HW, Watring WG (1988) A comparison of the Papanicolaou smear and the Cervigram: sensitivity, specificity and cost analysis. Obstet Gynecol 71:229–233.

    PubMed  CAS  Google Scholar 

  78. van der Graaf Y, Zielhuis G, Peer P, Vooijs P (1988) The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol 41:21–26.

    Article  PubMed  Google Scholar 

  79. van Wijngaarden WJ, Duncan ID (1993) Rationale for stopping cervical screening in women over 50. Br Med J 306:967–971.

    Article  Google Scholar 

  80. Vessey MP, Lawless M, McPherson K et al. (1983) Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet ii:930–934.

    Article  Google Scholar 

  81. World Health Organization Report (1986) Control of cancer of the cervix uteri. Bull World Health Organ 64:607–618.

    Google Scholar 

  82. Ziegler RG, Brinton LA, Hamman RF et al. (1990) Diet and the risk of invasive cervical cancer among white women in the United States. Am J Epidemiol 132:432–445.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Sue Moss
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cancer Screening Evaluation Unit, Section of Epidemiology, Institute of Cancer Research, Block D, Cotswold Road, Sutton, Surrey, SM2 5NG, UK

    Jocelyn Chamberlain  & Sue Moss  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag London Limited

About this chapter

Cite this chapter

Moss, S. (1996). Screening for Cancer of the Cervix. In: Chamberlain, J., Moss, S. (eds) Evaluation of Cancer Screening. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-3044-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3044-4_2

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-19957-1

  • Online ISBN: 978-1-4471-3044-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation